Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
Think you know your Disney movies? There’s no better way to put that theory to the test than taking on Disney trivia questions. The company’s been churning out classics since Snow White and the Seven ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results